Immunological markers as predictors of locally advanced disease and biochemical recurrence in patients with intermediate-risk prostate cancer after radical prostatectomy
Background. Systemic inflammation is considered as a significant factor in the pathogenesis and progression of prostate cancer. Despite the leading role of standard clinical and laboratory parameters in assessing the aggressiveness of the disease, literature data demonstrate potential prognostic value of immunological...